|Year : 2020 | Volume
| Issue : 2 | Page : 327-331
Carcinosarcoma: A rare case report of a recurrent mass in the neck region
Dinshaw Hormuzdi1, Sharad Desai2, Sushma Bommanavar3, Dipti Patil1
1 Department of Head and Neck Surgery Unit, Mahatma Gandhi Cancer Hospital, Miraj, Maharashtra, India
2 Department of Onco Surgery, Mahatma Gandhi Cancer Hospital, Miraj, Maharashtra, India
3 Department of Oral Pathology and Microbiology and Forensic Odontology, School of Dental Sciences, Krishna Institute of Medical Sciences, Karad, Maharashtra, India
|Date of Submission||26-Mar-2020|
|Date of Decision||18-May-2020|
|Date of Acceptance||08-Jun-2020|
|Date of Web Publication||09-Sep-2020|
Department of Oral Pathology and Microbiology, School of Dental Sciences, Krishna Institute of Medical Sciences, KIMSDU, Karad, Maharashtra
Source of Support: None, Conflict of Interest: None
| Abstract|| |
Carcinosarcoma, a biphasic malignant mixed tumor, is an extremely rare neoplasm with >1% incidence. This aggressive malignancy is characterized by the presence of two components admixed with each other, i.e., the epithelial component and the mesenchymal component arising from a monoclonal/multiclonal origin or de novo. Most patients usually present between 60 and 65 years of age with no sex predilection. The authors present a case of carcinosarcoma arising as a mass in the neck region of a 14-year-old male. The case is been presented for its rarity of occurrence in the younger age group.
Keywords: Carcinosarcoma, head and neck neoplasm, mixed tumor, recurrent mass, supraclavicular region, young adult
|How to cite this article:|
Hormuzdi D, Desai S, Bommanavar S, Patil D. Carcinosarcoma: A rare case report of a recurrent mass in the neck region. J Oral Maxillofac Pathol 2020;24:327-31
|How to cite this URL:|
Hormuzdi D, Desai S, Bommanavar S, Patil D. Carcinosarcoma: A rare case report of a recurrent mass in the neck region. J Oral Maxillofac Pathol [serial online] 2020 [cited 2021 Aug 1];24:327-31. Available from: https://www.jomfp.in/text.asp?2020/24/2/327/294603
| Introduction|| |
Carcinosarcoma, an aggressive biphasic malignant neoplasm with both epithelial and mesenchymal components is extremely rare tumor that accounts for about >1% of all malignancies., Way back to history, during early 1989, the total cases documented were up to 20 cases. In 1993, a slight numerical rise of about 60 cases were documented. Recent statistical data revised till date revealed up to 73 cases. This modest rise in the occurrence of this malignancy over decades has raised the curiosity among researchers to explore this tumor in detail and identify the best treatment modalities.
By definition, carcinosarcoma is composed of two components, i.e., epithelial and mesenchymal components giving a biphasic appearance. It was first described in 1951 by Kirklin et al. and labeled as “carcinosarcoma” by Virchow in 1864., King Jr. in 1976 was the first to use the term “True Malignant Mixed Tumor” for this malignancy. Thereafter, various authors described a wide range of terminologies for this baffling malignancy as spindle cell carcinoma, pseudosarcoma and squamous cell carcinoma with pseudosarcoma. Carcinosarcoma are usually seen in elderly patients (6th–7th decade), although a wide range from 14 to 87 years does exist, with a slight male predilection. It is thought to arise from larynx, hypopharynx, esophagus, trachea, nasal cavity and oral mucosa.,,,, Irrespective of its origin, this aggressive tumor has a poor prognosis. Recurrent mass in the neck region in younger age groups are uncommon, and this article presents one such rare case.
| Case Report|| |
An Indian 14-year-old male was addressed to the Department of Head and Neck Surgery, Mahatma Gandhi Cancer Hospital, South Maharashtra, India, with a chief complaint of a tender mass on the right side of the neck of 2 years duration. The patient's medical history revealed a previous open biopsy, which was undertaken in another institute, details of which were untraceable except for the biopsy report that revealed carcinosarcoma. The present mass reported on December 10, 2019, measured approximately about 10 cm × 8 cm in size extending from the right mid-neck at the level of C3 vertebrae region till the right supraclavicular region and was associated with pain. The photographs of the recurrent mass were taken after due consent from the patient for documentation [Figure 1]. On clinical examination, a well defined, lobulated, tender mass that was hard in consistency was felt on palpation. The mass was mobile and not fixed to the deeper structures and planes of the neck region. The overlying skin was tense and taut. Level III and IV lymph nodes were palpable. There were no other systemic symptoms involved or associated.
|Figure 1: Depicts well defined, lobulated, hard tender mass on the neck region|
Click here to view
On contrast enhanced computed tomography (CT) imaging of the right side of the neck, a 7 cm (crainocaudal) × 6.2 cm (anteroposterior) × 4.7 cm (transverse) lobulated heterogeneously enhancing lesion on the subclavicualr/clavicular regions, abutting the right sternocleidomastoid and right paraspinal muscles with sharp emarginated borders was seen. An intraluminal hypodense area of 2.3–1.0 cm was noticed within the right subclavian vein suggestive of a tumor thrombus. The lymph nodes were assessed on the long axis, in which one node in the right posterior triangle area revealed 1.5 cm enlargement, indicative of metastasis. On further evaluation, adjacent anatomical structures such as nasopharnyx, torus tubarius, oropharyngeal airway, hyoid bone, epiglottis, thyroid gland, esophagus, larynx, tongue, muscles of mastication and all the major salivary glands/salivary ducts were normal. CT thorax and ultrasonography abdomen were done to rule out any systemic disease or metastasis. Clinical differential diagnosis of malignant tumor of the neck was considered. The patient, being minor, signed consent from his parents was taken before the surgery. They were also informed in brief about the biological behavior of the tumor and the type of surgery planned based on the tumor characteristics.
Sternotomy followed by the opening of the thorax, the right superior major venous system and the “innominate vein” was dissected and prepared. The venous angle was dissected, and an emergency ligation of the subclavian vein was planned before its resection and repair. En bloc resection of the tumor was planned and performed that involved a circumferential incision around the tumor skin margin and part of the sternocleidomastoid muscle, Level II, III, IV and lymph nodes were dissected along with the tumor mass. Part of the clavicle, which was involved by the tumor mass, was also resected en bloc. The subclavian vein that showed an intraluminal hypodense area on CT was clamped and partly resected, followed by its mobilization and repair of the remaining proximal and distal stumps. Hemostasis was achieved. The thorax was closed meticulously. The resected defect was calculated, and accordingly, a pectoralismyocutameous flap was harvested from the right side along with the skin paddle, which was rotated 180° and inset done [Figure 2], [Figure 3], [Figure 4]. Histopathological evaluation of the resected mass showed characteristics of biphasic histological pattern with adenocarcinoma and sarcomatous elements displaying atypical large cells with irregular nuclear contour and prominent nucleoli with vascular, lymphatic and perineural invasion. At places, necrosis and calcifications are also evident [Figure 5]. MIB 2 positivity for imuunohistochemical analysis was done [Figure 6].
|Figure 2: Depicts intra-operative picture showing internal jugular vein retracted by white elastic band and the subclavian vein retracted by blue band|
Click here to view
|Figure 3: Depicts postresection of the tumor and repair of the subclavian vein|
Click here to view
|Figure 4: Depicts reconstruction and inset of the pectoralis myocutaneous flap into the neck defect, final closure|
Click here to view
|Figure 5: H and E stained section shows large pleomorphic malignant cells demonstrating cellular atypia and vascular invasion|
Click here to view
| Discussion|| |
According to the World Health Organization and Armed Forces Institute of Pathology, Carcinosarcoma belongs to the group of true malignant mixed tumors, accounting for about<1%.,, Traced back to the historiography of this lesion, the term “malignant mixed tumor” was used for carcinomas arising in pleomorphic adenomas (carcinoma ex pleomorphic adenoma), sarcomas arising in pleomorphic adenoma (sarcoma ex pleomorphic adenoma), true malignant mixed tumors (carcinosarcoma), and the controversial entity “benign metastasizing pleomorphic adenoma.”,, Finally, the term was coined by King Jr. in 1976. Most commonly, it occurs in larynx, hypopharynx, esophagus, trachea, nasal cavity and oral mucosa among elderly individuals with slight male predominance.,,,,
The histogenesis is quite controversial. Initially, it was thought to arise from benign pleomorphic adenoma. In 1993, Gnepp et al. documented 43 cases of carcinosarcoma with a mean age of occurrence being 14–87 years with no sex prediction., Among all these cases, only 7 cases showed the histological evidence of preexisting pleomorphic adenoma and 4 cases did not show any such correlation. Later, numerous studies revealed the biphasic potential of this tumor, demonstrating the epithelial and mesenchymal components. Beyond the shadow of doubt, three dominant enigmatic theories were finally proposed for this malignancy as follows:
- The first hypothesis stated that the tumor represents a collision tumor or squamous cell carcinoma with atypical reactive stroma resembling “pseudosarcoma”.,,
- The second hypothesis stated it to be of epithelial origin, with “de-differentiation” or transformation to a spindle cell morphology (sarcomatoid carcinoma)
- The third hypothesis stated it to be of both epithelial and mesenchymal origin. This was further authenticated by the following observation of the occurrence of this lesion in exact sites which have the squamous epithelium, its polypoid appearance, direct contact and smooth transition of spindle cells with squamous cells and the immunohistochemical (IHC) profile displaying both markers for epithelial and mesenchymal origin., Hence to summarize the mysterious, baffling mechanism and histogenesis, two antithetical hypotheses called Convergence hypothesis and Divergence hypothesis were formulated in which the former showed a multiclonal origin arising from two or more stem cells and the later showed a monoclonal origin arising from a single totipotential stem cell that differentiates in separate epithelial and mesenchymal directions.,
Being composed of both malignant epithelial component and malignant mesenchymal component, it shows specific diversity on histological examination. The epithelial component demonstrates well-differentiated keratinizing (with keratin pearls evident) or poorly differentiated non-keratinizing squamous cell carcinoma areas (no keratin pearls evident) in which squamous cells are arranged in sheets, cords, and bundles separated by varying amounts of vascular connective tissue. The epithelial component also shows adenocarcinomatous characteristics, as seen in a case study documented by Kwon and Gu as well as in our present case. The mesenchymal component demonstrates chondrosarcoma, followed by fibrosarcoma, leiomyosarcoma, osteosarcoma, and liposarcoma. Sarcoma-like, malignant features such as hypercellularity, marked pleomorphism, and enlarged nuclei are also evident similar to our case. The differential diagnosis, in this case, could be pleomorphic ex adenoma, squamous cell carcinoma, Juxtaoral organ of Chievitz and adenoid carcinoma.,, The IHC profiling with cytokeratin AE1/AE3, vimentin, S-100 and anti smooth muscle actin can be helpful in differentiating carcinomatous and sarcomatous components. Molecular and genetic studies conducted by Gotte et al.in 2000 inferred that inactivated form tumor suppressor gene on Chromosome 17 and a wild-type allele of the p53 tumor suppressor gene play a role, thus favoring the monoclonal origin. Recently, Xin andPaulino found that Ki67 can a useful prognostic marker and plays an important role in carcinogenesis. Semczuk et al. in his study evaluated proliferative activity using IHC analysis of carcinomatous and sarcomatous components with a panel of anitibodies BCL 2, CD10, COX 2, HER 2, MIB, etc., in uterine carcinosarcoma. The results inferred that the proliferative activity was more in carcinomatous components than the sarcomatous components. The present case report also showed the same result when immunostained with MIB 2 [Figure 6].
The treatment is a radical surgical resection, which should be combined with radiation and chemotherapy. Our case was treated by en bloc resection of the tumor along with the involved structure followed by adjuvant radiotherapy. In the literature, recurrence occurs in approximately two-thirds of patients and metastases in about half of them. The median period of survival after diagnosis is 10 months in 63%. In the present case, the rare occurrence of carcinosarcoma in the younger age group creates a hypothesis that needs to be further explored for better understanding of the pathogenesis, which can be correlated with the recurrence and proper treatment plan.
| Conclusion|| |
The case reported in this article is a carcinosarcoma (CRS), which combines both carcinomatous and sarcomatous components. It is reported because of its rare occurrence in the neck in the younger age group. Although the number of reported cases is less, the combination of radical surgical excision and radiotherapy not always seems to be the treatment of choice for CRS currently.
Declaration of patient consent
The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Fowler MH, Fowler J, Ducatman B, Barnes L, Hunt JL. Malignant mixed tumors of the salivary gland: A study of loss of heterozygosity in tumor suppressor genes. Mod Pathol 2006;19:350-5.
Singh G, Sharma D. Carcinosarcoma of head and neck; clinicopathological characteristics, treatment and outcomes of unique neoplasm. Int J Radiol Radiat Ther 2017;3:269-70.
Garner SL, Robinson RA, Maves MD, Barnes CH. Salivary gland carcinosarcoma: True malignant mixed tumor. Ann Otol Rhinol Laryngol 1989;98:611-4.
Kwon MY, Gu M. True malignant mixed tumor (carcinosarcoma) of parotid gland with unusual mesenchymal component: A case report and review of the literature. Arch Pathol Lab Med 2001;125:812-5.
Feng D, Fidele NB, Agustin MM, Jian G, Bourleyi SI, Augustin L, et al
. Carcinosarcoma of parotid gland (malignant mixed tumor). Ann Maxillofac Surg 2015;5:240-3.
] [Full text]
Wu CC, Chou YH, Wang YT, Lee YC, Tseng HC. Carcinoma ex pleomorphic adenoma of the parotid gland: A case report. Ther Radiol Oncol 2016;23:129-35.
Kirklin JW, Mcdonald JR, Harrington SW, New GB. Parotid tumors; histopathology, clinical behavior, and end results. Surg Gynecol Obstet 1951;92:721-33.
Berthelet E, Shenouda G, Black MJ, Picariello M, Rochon L. Sarcomatoid carcinoma of the head and neck. Am J Surg 1994;168:455-8.
Shakil M, Mohtesham I, Jose M. Histopathological, immunohistochemical and special stain unraveling the enigmatic carcinosarcoma – A case report. J Cancer Res Ther 2015;11:656.
King OH Jr. Carcinosarcoma of accessory salivary gland. First report of a case. Oral Surg Oral Med Oral Pathol 1967;23:651-9.
Viswanathan S, Rahman K, Pallavi S, Sachin J, Patil A, Chaturvedi P, et al
. Sarcomatoid (spindle cell) carcinoma of the head and neck mucosal region: A clinicopathologic review of 103 cases from a tertiary referral cancer centre. Head Neck Pathol 2010;4:265-75.
Kumar T, Kothari K, Patel MH, Kumar P, Ravi K, Yadav V. Carcinosarcoma of upper aerodigestive tract: A case series. Indian J Surg Oncol 2011;2:316-9.
Mansour J, Mangaonkar A, Kota V. Recurrent parotid carcinosarcoma in an asymptomatic patient. J Investig Med High Impact Case Rep 2016;4:1-3.
Keh SM, Tait A, Ahsan F. Primary carcinosarcoma of the parotid gland. Clin Pract 2011;1:e117.
Woo CG, Son SM. Carcinosarcoma of the parotid gland with abdominal metastasis: A case report and review of literature. World J Surg Oncol 2018;16:103.
Barnes L, Eveson J, Reichart PA. Lymphoepithelialcarcinoma. In: Kleihues P, Sobin LH, editors. World Health Organization Classification of Tumors: Pathology & Genetics of Head and Neck Tumors. Lyon: IARC Press; 2005. p. 18.
Ellis GL, Auclair PL. Tumors of the Salivary Glands. Washington, DC: Armed Forces Institute of Pathology, Atlas of Tumor Pathology; 1996.
el-Naggar A, Batsakis JG, Kessler S. Benign metastatic mixed tumours or unrecognized salivary carcinomas? J Laryngol Otol 1988;102:810-2.
Batsakis JG. Malignant mixed tumor. Ann Otol Rhinol Laryngol 1982;91:342-3.
Stephen J, Batsakis JG, Luna MA, von der Heyden U, Byers RM. True malignant mixed tumors (carcinosarcoma) of salivary glands. Oral Surg Oral Med Oral Pathol 1986;61:597-602.
Gnepp DR. Malignant mixed tumors of the salivary glands: A review. Pathol Annu 1993;28 Pt 1:279-328.
Middlehurst RJ, Blackburn CW, Sloan P. Spinde-cell carcinoma: A case report. Br J Oral Maxillofac Surg 1990;28:114-6.
Goellner JR, Devine KD, Weiland LH. Pseudosarcoma of the larynx. Am J Clin Pathol 1973;59:312-26.
Huang SF, Chen IH, Liao CT, Chen TM, Lee KF. Sarcomatoid carcinoma of the parotid gland with apparent metastasis of epidermoid elements to cervical lymph nodes. Acta Otolaryngol 2006;126:667-71.
Thompson LD, Wieneke JA, Miettinen M, Heffner DK. Spindle cell (sarcomatoid) carcinomas of the larynx: A clinic pathologic study of 187 cases. Am J Surg Pathol 2002;26:153-70.
Thompson L, Chang B, Barsky SH. Monoclonal origins of malignant mixed tumors (carcinosarcomas). Evidence for a divergent histogenesis. Am J Surg Pathol 1996;20:277-85.
Bommanavar SB, Hema KN, Baad R. Juxtaoral organ of Chievitz: An innocuous organ to be known. J Oral Maxillofac Pathol 2017;21:162-4.
] [Full text]
Toynton SC, Wilkins MJ, Cook HT, Stafford ND. True malignant mixed tumour of a minor salivary gland. J Laryngol Otol 1994;108:76-9.
Xin W, Paulino AF. Prognostic factors in malignant mixed tumors of the salivary gland: Correlation of immunohistochemical markers with histologic classification. Ann Diagn Pathol 2002;6:205-10.
Semczuka A, Skomrab D, Chyzynskab M, Szewczuka W, Olchaa P, Korobowicz E. Immunohistochemical analysis of carcinomatous and sarcomatous components in the uterine carcinosarcoma: A case report. Pathol Res Pract 2008;204:203-7.
Patnayak R, Jena A, Raju G, Uppin S, SatishRao I, Sundaram C. Carcinosarcoma of the parotid gland: A case report and short review of literature. Internet J Oncol 2007;5:1-7.
Bhalla RK, Jones TM, Taylor W, Roland NJ. Carcinosarcoma (malignant mixed tumor) of the submandibular gland: A case report and review of the literature. J Oral Maxillofac Surg 2002;60:1067-9.
[Figure 1], [Figure 2], [Figure 3], [Figure 4], [Figure 5], [Figure 6]